Salome Meyer (@salomemeyer1) 's Twitter Profile
Salome Meyer

@salomemeyer1

Independent CANCER Advocate/Activist I Living with Purpose I Access to Equitable Care l Human Rights l Policy and Law @Cancer_ZA
canceralliance.co.za

ID: 621069389

calendar_today28-06-2012 15:20:09

2,2K Tweet

966 Followers

1,1K Following

Salome Meyer (@salomemeyer1) 's Twitter Profile Photo

Cancer is not Pink! No there are other colours as well such as blue Global Colon Cancer Association says Tumi Ramasodi! Thank you for speaking up! Faizel Jacobs this journey is a shared safe space. #wecanmakeadifference #togetherwecan Cancer Alliance ZA

Cancer is not Pink! No there are other colours as well such as blue <a href="/GlobalCRC/">Global Colon Cancer Association</a> says Tumi Ramasodi! Thank you for speaking up! <a href="/FaizelOstomate/">Faizel Jacobs</a> this journey is a shared safe space. #wecanmakeadifference #togetherwecan <a href="/Cancer_ZA/">Cancer Alliance ZA</a>
Bhekisisa (@bhekisisa_mg) 's Twitter Profile Photo

Archive: This country plans to eliminate cervical cancer (one of the biggest killers of women in SA) by 2060. Could we learn from them? Salome Meyer says yes. bhekisisa.org/opinion/2022-0…

Archive: This country plans to eliminate cervical cancer (one of the biggest killers of women in SA) by 2060. Could we learn from them? <a href="/SalomeMeyer1/">Salome Meyer</a> says yes. bhekisisa.org/opinion/2022-0…
Salome Meyer (@salomemeyer1) 's Twitter Profile Photo

This is a pattern now with mAB’s! First IV profit , then SQ patent to make more money and keep out of reach for LMICs. Roche did same with trastuzumab! equitable and affordable access denied! MedicinesPatentPool @SharonannLynch Unitaid SQ is more affordable for health systems!

Unitaid (@unitaid) 's Twitter Profile Photo

The future of global health depends on addressing women’s health but progress has stalled. Unitaid is scaling up affordable HPV tests & thermal ablation to prevent cervical cancer, already reaching 1.5M women. We must expand access and scale these innovations to save more lives.

Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo

Keytruda is a cancer treatment that is marketed by Merck. It carries a list price of over $200,000 per year. We investigated the patenting strategies around Keytruda. Here's what we found: 📄180 patent applications have been filed 📄78 patents have been granted These granted

Keytruda is a cancer treatment that is marketed by Merck. It carries a list price of over $200,000 per year.

We investigated the patenting strategies around Keytruda. Here's what we found:

📄180 patent applications have been filed
📄78 patents have been granted 

These granted
Unitaid (@unitaid) 's Twitter Profile Photo

Women’s health is typically under-prioritized and under-funded. Closing the women’s health gap could prevent 27 million lost healthy years annually and unlock $400 billion in economic potential by 2040. #wef25 Find out more: weforum.org/publications/b…

Tahir Amin (@realtahiramin) 's Twitter Profile Photo

McKinsey literally gave AbbVie a playbook on how to improve their existing patent abuse strategies. documentcloud.org/documents/2111…

McKinsey literally gave AbbVie a playbook on how to improve their existing patent abuse strategies.
documentcloud.org/documents/2111…
Tahir Amin (@realtahiramin) 's Twitter Profile Photo

The FTC published 4 reports on patent settlements and, for the first time, highlighted volume restrictions. Volume restrictions are another way branded pharma companies restrict competition. Example: Celgene/Bristol Myers Squibb’s (BMS) patent settlement for Revlimid. 🧵

The FTC published 4 reports on patent settlements and, for the first time, highlighted volume restrictions.

Volume restrictions are another way branded pharma companies restrict competition.

Example: Celgene/Bristol Myers Squibb’s (BMS) patent settlement for Revlimid. 🧵
Tahir Amin (@realtahiramin) 's Twitter Profile Photo

Five bills addressing the pharmaceutical industry’s patent abuse passed out of the Senate Judiciary Committee last week.🧵

Five bills addressing the pharmaceutical industry’s patent abuse passed out of the Senate Judiciary Committee last week.🧵
Unitaid (@unitaid) 's Twitter Profile Photo

Cervical cancer claims the lives of 350,000 women each year, with 94% of deaths occurring in low- and middle-income countries. Unitaid’s recent report outlines innovative technologies that can prevent these deaths.👇 unitaid.org/news-blog/unit…

Emma Freer (@freer_emma) 's Twitter Profile Photo

"The company is motivated financially to maintain its monopoly as long as it can, to preserve its ability to charge higher prices as long as it can. [...] And there are patients who are being harmed in the meantime.” news.bloomberglaw.com/ip-law/mercks-…

Initiative for Medicines, Access & Knowledge (@imakglobal) 's Twitter Profile Photo

Merck is changing the way Keytruda is delivered, from an IV infusion to a subcutaneous injection, so it can thwart biosimilar competition and continue price gouging people with cancer. It's a tactic known as “product hopping" and it's a form of patent abuse. Here’s how it works.